Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for B2V4G9

Entry ID Method Resolution Chain Position Source
AF-B2V4G9-F1 Predicted AlphaFoldDB

No variants for B2V4G9

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for B2V4G9

No associated diseases with B2V4G9

6 regional properties for B2V4G9

Type Name Position InterPro Accession
domain Translational (tr)-type GTP-binding domain 186 - 355 IPR000795
domain Small GTP-binding protein domain 190 - 345 IPR005225
domain Translation initiation factor IF-2, N-terminal 1 - 49 IPR006847-1
domain Translation initiation factor IF-2, N-terminal 111 - 160 IPR006847-2
domain Translation initiation factor IF- 2, domain 3 465 - 576 IPR023115
domain Translation initiation factor IF-2, domain II 361 - 456 IPR044145

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

3 GO annotations of molecular function

Name Definition
GTP binding Binding to GTP, guanosine triphosphate.
GTPase activity Catalysis of the reaction: GTP + H2O = GDP + H+ + phosphate.
translation initiation factor activity Functions in the initiation of ribosome-mediated translation of mRNA into a polypeptide.

No GO annotations of biological process

Name Definition
No GO annotations for biological process

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MSKIRVYELA KELNVSSKDL ITLLMDEFGV EVKNHMSAIE DEEAQLIKEL LATKPEYVEG
70 80 90 100 110 120
SLEDSKSLVD EYEEILQNEL NKAKKKRKKN KREDKDDENE ELETEVIEIG ETITVKELAE
130 140 150 160 170 180
KLNKPSNDVI RTLIFSGVMA AINQEIDFAT AEKVCESYGV ILEKLEVIEE LEAVEVEEDD
190 200 210 220 230 240
EENLEKRPPI VTVMGHVDHG KTSLLDAIRK AKVTDTEAGG ITQHIGAYTI NINGEEITFL
250 260 270 280 290 300
DTPGHEAFTA MRARGAQVTD VVILVVAADD GIMPQTKEAI NHCKAAGVPM VVAINKIDKP
310 320 330 340 350 360
GANPDRVKQE LTEHGLVVEE WGGDTICEEV SAKSNLNIEK LLEMVLLTAE MLELKANKER
370 380 390 400 410 420
KAKGTVIEAK LDKGRGPVAT LLVQNGTLHV GDAIIVGSTY GRIRAMFDDT GKKIKSAGPS
430 440 450 460 470 480
IPVEVLGLSE VPEAGDRFNQ VKDEKTARIM ADKRKDKEKS DSLMSGNRVS LEDLYSQIKE
490 500 510 520 530 540
GKVKELGIIV KADVQGSVQA INQSLEKLST DDVKVRVIHG GVGAITETDI TLATASNAIV
550 560 570 580 590 600
IGFNVRPDNN AVAQADKENV EIKTYRIIYD AIEDVKSAMI GMLEPEYKEV ILGSAEVRET
610 620 630 640 650 660
YKISNVGTIA GCYVLNGKLQ RNAETRVIRD GIVIFESSLS SLKRFKDDVK EVNTGYECGL
670 680
TVEKFNDVKE GDILECFMME AIKRKEL